Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
11/06/2008 | CA2683488A1 Use of 4-(nitrooxy)-butyl-(s)-2-(6-methoxy-2-naphtyl)-propanoate for treating pain and inflammation |
11/06/2008 | CA2679658A1 Fusion proteins binding to growth factors |
11/06/2008 | CA2667621A1 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production |
11/05/2008 | EP1988102A1 Growth factor homolog ZVEGF3 |
11/05/2008 | EP1988091A1 Tricyclic compounds |
11/05/2008 | EP1988081A1 Binding inhibitor of sphingosine-1-phosphate |
11/05/2008 | EP1987842A1 Cell proliferation inhibitor |
11/05/2008 | EP1987823A1 Condensation aerosol containing zaleplon for inhalation |
11/05/2008 | EP1987036A1 Hetero-bycyclic antiviral compounds |
11/05/2008 | EP1987032A1 3, 9-diazabicyclo(3.3.1)non-3-yl-aryl methanone derivatives as nicotinic acetylcholine receptor agonists |
11/05/2008 | EP1987031A1 3-heteroaryl- 3,9-diazabicyclo[3.3.1]nonane derivatives as nicotinic acetylcholine receptor agonists |
11/05/2008 | EP1987013A1 Bicyclic sphingosine 1-phosphate analogs |
11/05/2008 | EP1987010A1 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
11/05/2008 | EP1987009A1 Cyclourea compounds as calcium channel blockers |
11/05/2008 | EP1986747A2 Quinolones useful as inducible nitric oxide synthase inhibitors |
11/05/2008 | EP1986658A2 Ibandronate new regimen for treating metastatic bone pain |
11/05/2008 | EP1986628A2 Methods and compositions for treating hyperalgesia |
11/05/2008 | EP1986627A2 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases |
11/05/2008 | EP1986621A1 Use of resveratrol and derivatives thereof for promoting the wellness state in mammals |
11/05/2008 | EP1713781B1 Quinazoline derivatives |
11/05/2008 | EP1663970B1 Matrix metalloproteinase inhibitors |
11/05/2008 | EP1487828B1 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases |
11/05/2008 | EP1465996B1 Raf/ras binding compounds |
11/05/2008 | EP1385514B1 Spiroindene and spiroindane compounds |
11/05/2008 | EP1363937B1 Immunomodulating agents from parasitic worms and method for isolation thereof |
11/05/2008 | EP1341811B9 Orally ingestible preparation of mistletoe lectins and method |
11/05/2008 | EP1309544B1 Compounds acting as melanocortin receptor ligands |
11/05/2008 | EP1216247B1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
11/05/2008 | CN101300259A Tricyclic spiro derivatives as CRTH2 modulators |
11/05/2008 | CN101300255A Imidazolone phenylalanine derivatives as VLA-4 antagonists |
11/05/2008 | CN101300236A Triazole compounds as lipoxygenase inhibitors |
11/05/2008 | CN101300233A Azafused cyclin dependent kinase inhibitors |
11/05/2008 | CN101298481A Inhibitors of complement activation |
11/05/2008 | CN101298440A Pharmaceutical salts of reboxetine |
11/05/2008 | CN101298415A Preparation of non-steroidal anti-inflammatory medicine biphenylacetic acid |
11/05/2008 | CN101297965A Applications of thymic peptide beta4 in preparing medicament for preventing and treating bronchial asthma |
11/05/2008 | CN101297948A Chinese medicine lotion preparation for treating chest wall soft tissue injury |
11/05/2008 | CN101297946A Plaster for activating blood and resolving stasis, dispelling wind and freeing collateral vessels and producing method thereof |
11/05/2008 | CN101297943A Medicinal liquor for strengthening bones and muscles and treating rheumatism |
11/05/2008 | CN101297942A Itch-reliving detumescence agent containing plant vinegar liquid and preparation thereof |
11/05/2008 | CN101297908A Liver-tonifying kidney-boosting medicinal liquor |
11/05/2008 | CN101297896A Method for extracting antipyretic and detoxicated oral liquid using cellulase |
11/05/2008 | CN101297895A Pure Chinese medicinal liquor for treating bone regeneration |
11/05/2008 | CN101297891A Medicinal liquor for activating blood circulation, removing stasis and strengthening spleen |
11/05/2008 | CN101297878A Preparation technique of high-content white peony root effective composition |
11/05/2008 | CN101297877A Preparation of white peony root total glycosides granules |
11/05/2008 | CN101297876A Novel method for preparing white peony root total glycosides extract |
11/05/2008 | CN101297875A Preparation of white peony root total glycosides capsules |
11/05/2008 | CN101297874A Technique for extracting high-content effective composition from white peony root |
11/05/2008 | CN101297841A Compound Tripterygium wilfordii multi-glycosides formulation for curing rheumatic disease and preparation method thereof |
11/05/2008 | CN101297826A Compound Bupleurum injection for curing common cold of dog and preparation thereof |
11/05/2008 | CN101297805A Medicament composition for preventing and controlling enteritis necroticans of domestic birds |
11/05/2008 | CN101297804A Medical use of iso-papaverine |
11/05/2008 | CN101297790A Zaltoprofen sustained-release preparation and preparation thereof |
11/05/2008 | CN101297667A Dandelion health-care tea and preparing process thereof |
11/05/2008 | CN100430383C Benzimidazoles that are useful in treating sexual dysfunction |
11/05/2008 | CN100430067C Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof |
11/05/2008 | CN100430052C Cathepsin cysteine protease inhibitors |
11/05/2008 | CN100430048C Alpha-2-delta ligand to treat lower urinary tract symptoms |
11/04/2008 | US7446222 2-benzyloxy-5-chloro-[1,1';2',1'']terphenyl-3''-carboxylic acid; neuropathic pain; chronic articular pain (e.g. rheumatoid arthritis, osteoarthritis, rheumatoid spondylitis, gouty arthritis and juvenile arthritis) including the property of disease modification and joint structure preservation |
11/04/2008 | US7446183 Fusion protein comprising growth hormone and growth hormone receptor |
11/04/2008 | US7446175 Antibodies to human IL-1β |
11/04/2008 | US7446173 amino acid sequence coupled to a non-naturally-occurring polyoxyalkylene glycol at N-terminal end of glycosylated interferon-beta-1a through a coupling group such as aldehyde, maleimide, a vinylsulfone,or haloacetate groups; enhanced activity; Multiple sclerosis; cancer; therapeutical; water solubility |
11/04/2008 | US7446117 Cox-2 inhibiting pyridine derivatives |
11/04/2008 | US7446109 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
11/04/2008 | US7446106 Pyridylfurans and pyrroles as Raf kinase inhibitors |
11/04/2008 | US7446105 4-(1,2-diethyl-4-methylimidazol-5-yl)-2-{4-[N-(2-methoxyethyl)sulphamoyl]anilino}pyrimidine; selectivity for cyclin-dependent serine/threonine kinases (CDK2, CDK4 and CDK6); antiproliferative agent; minimize pharma toxicity on S-phase cell cycle, G2 or mitosis; oncogene signalling pathways |
11/04/2008 | US7446097 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
11/04/2008 | US7446091 Methods and preparations for curing clinically ill patients |
11/04/2008 | US7445928 Bacterial artificial chromosome construct encoding recombinant coronavirus |
11/04/2008 | US7445903 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis |
11/04/2008 | US7445780 Antagonistic anti-CD40 antibodies |
11/04/2008 | US7445768 Delivery of sedative-hypnotics through an inhalation route |
11/04/2008 | US7445764 Carrier-drug conjugate |
11/04/2008 | CA2457361C Opioid agonist formulations with releasable and sequestered antagonist |
11/04/2008 | CA2255521C Compositions for treatment of burns |
10/30/2008 | WO2008130953A2 2-imin0is0thiaz0le derivatives as cannabinoid receptor ligands |
10/30/2008 | WO2008130879A2 Tetrahydroindole and tetrahydroindazole derivatives |
10/30/2008 | WO2008130323A1 Novel 8-piperazine-tetrahydronaphtalene derivatives for the treatment of pain |
10/30/2008 | WO2008130322A1 Novel 5-heterocyclyl-chromane derivatives for the treatment of pain |
10/30/2008 | WO2008129280A1 Pyrazoles useful in the treatment of inflammation |
10/30/2008 | WO2008129276A1 Disulfonamides useful in the treatment of inflammation |
10/30/2008 | WO2008129270A2 Compositions comprising anti-inflammatory compounds |
10/30/2008 | WO2008129258A1 New use for cannabinoid-containing plant extracts |
10/30/2008 | WO2008129129A1 Heterocyclic phenyl carbamates as novel faah-inhibitors |
10/30/2008 | WO2008129071A1 Inhibitors of protein kinases |
10/30/2008 | WO2008129070A1 Inhibitors of protein kinases |
10/30/2008 | WO2008129069A1 Inhibitors of protein kinases |
10/30/2008 | WO2008128832A1 Nitroderivatives of non-peptidic renin inhibitors for the treatment of cardiovascular, renal and chronic liver disease, inflammations and metabolic syndrome |
10/30/2008 | WO2008128456A1 The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof |
10/30/2008 | WO2008128343A1 Boron-containing compounds, uses and preparation thereof |
10/30/2008 | WO2008128321A1 Therapeutic pro-antibiotic agents and methods of use thereof |
10/30/2008 | WO2008109380A3 Nucleic acid compounds for inhibiting vegfr family gene expression and uses thereof |
10/30/2008 | WO2008087323A3 Galenic form for the transmucosal delivery of paracetamol |
10/30/2008 | WO2008074752A3 Indolylmaleimide derivatives as kinase inhibitors |
10/30/2008 | US20080269465 Tumor necrosis factor specific immunoglobulin for use in prevention and treatment of rheumatoid arthritis, ulcerative colitis, multiple sclerosis and crohn's disease |
10/30/2008 | US20080269349 administering an isolated astaxanthin and a mono- or di-ester thereof; controlling cytokine or TGF- alpha -related gene expression; reducing muscle atrophy, treating diabetes |
10/30/2008 | US20080269339 antiinflammatory mixture for treating chronic inflammatory skin disease, not limited to psoriasis; Calcipotriol, Valproic acid, or suberolyanilide hydroxamic acid and ZD1839 (iressa, gefitinib), PD153035, or SU 5271; synergistic effect |
10/30/2008 | US20080269338 Aqueous solutions containing chloramine which are free from di-and trichloroamine, as well as from ammonia |
10/30/2008 | US20080269335 Crth2 Receptor Antagonists |